Breaking News
November 18, 2017 - Old World monkeys could hold key to stop progression of rheumatoid arthritis
November 18, 2017 - Harris Health System RNs named among 20 Outstanding Nurses for 2017
November 18, 2017 - Old World monkeys could be key to a new, powerful rheumatoid arthritis therapy
November 18, 2017 - Mount Sinai researchers identify new therapeutic target for ER+ breast cancer
November 18, 2017 - Age, CRP levels predict success in tapering of biologics in rheumatoid arthritis patients
November 18, 2017 - New dye could be used to observe electrical activity of neurons in the brain
November 18, 2017 - New study further validates use of vaginal progesterone to decrease risk of preterm birth
November 18, 2017 - Russian researcher determined range of reference values for boron in the human body
November 18, 2017 - ‘What the Health?’ Tax bill or health bill?
November 18, 2017 - Could Your Cat Give You ‘Bird Flu?’
November 18, 2017 - Vitamin D Linked to Fertility Outcomes in ART
November 18, 2017 - Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer’s disease
November 18, 2017 - Tax reform proposal could impact care for older Americans
November 18, 2017 - PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease
November 18, 2017 - Researchers receive £1.3 million to develop sight-saving imaging technology
November 18, 2017 - Novel buckypaper sensor could pave way for high-performance, affordable wearable technology
November 18, 2017 - Despite ACA cost protections, most adolescents skip regular checkups
November 18, 2017 - Stem cell treatment allows paraplegic rats to walk and regain sensory perception
November 18, 2017 - HTC analytical conference comes to the UK
November 18, 2017 - Face It: Drinking, Smoking Takes Toll on Looks: MedlinePlus Health News
November 18, 2017 - New research shows where in the brain the earliest signs of Alzheimer’s occur
November 18, 2017 - Philips announces launch of global movement to raise awareness for COPD
November 18, 2017 - University of Bristol awarded grant to reduce antibacterial drug resistance in Thailand
November 18, 2017 - New oxytocin chemical sensor could be first step towards early diagnosis of autism
November 18, 2017 - Study finds medical cannabis is effective at reducing opioid addiction
November 18, 2017 - Specially tailored, ultrafast light pulses can trigger neurons to fire in different patterns
November 18, 2017 - Decrease in sunshine linked to rising incidence of Rickets
November 18, 2017 - Harnessing social media big data to fight against prescription drug crisis
November 18, 2017 - Researchers find way to switch tumor cells between 2D and 3D morphology
November 18, 2017 - FDA Approves Hemlibra (emicizumab-kxwh) for Hemophilia A with Inhibitors
November 18, 2017 - Adolescents underreport amphetamine use, likely unaware that adderall is amphetamine
November 18, 2017 - Study reveals a reduced risk of teenage eczema in breastfed babies
November 18, 2017 - Separating side effects could pave way for safe, effective pain medications
November 18, 2017 - Gut bacteria at young age can contribute to MS disease onset and progression, study suggests
November 18, 2017 - Environmental triggers may play role in development of Lupus
November 18, 2017 - Review looks into conventional versus new treatment modalities in orthodontic pain management
November 17, 2017 - FDA Alert: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall
November 17, 2017 - For older women, every movement matters
November 17, 2017 - Talking-based therapy could transform aftercare for cancer survivors
November 17, 2017 - Olympus IXplore SpinSR10 imaging system enables researchers to observe fine details in live cells
November 17, 2017 - Study explores reasons for underrepresentation of minorities in genetic cancer research
November 17, 2017 - California firm running physician practices is closing down as scrutiny ramps up
November 17, 2017 - BMI not valid measure of obesity in postmenopausal women, study shows
November 17, 2017 - Vaginal progesterone decreases the risk of premature birth in women with short cervix
November 17, 2017 - Pricey ER Tests for Chest Pain Often Unnecessary
November 17, 2017 - ‘Old’ Lungs May Be Good Transplant Options: MedlinePlus Health News
November 17, 2017 - How not to gain weight over the holidays
November 17, 2017 - Researchers map first-ever proteome of healthy human heart
November 17, 2017 - Drug used to prevent and treat malaria may also be effective for Zika virus
November 17, 2017 - One in 20 children still receiving codeine to treat pain despite warning from federal regulators
November 17, 2017 - Improving clinical trials with machine learning
November 17, 2017 - Experts identify mental exercise program that can reduce risk of dementia
November 17, 2017 - Just-in-time 3-D implants set to transform tumor surgery
November 17, 2017 - Skin patch offers hope for people with peanut allergy
November 17, 2017 - Scientists identify biomarkers that predict risk of death in Ebola patients
November 17, 2017 - Heart attack, stroke patients have improved outcomes when statins are prescribed after discharge
November 17, 2017 - Majority of people do not understand link between obesity and cancer, study shows
November 17, 2017 - Deep vein thrombosis accurately diagnosed by GPs trained in compression ultrasonography
November 17, 2017 - New Kevlar-based hydrogel recreates the magic of natural cartilage
November 17, 2017 - FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence
November 17, 2017 - Foods made with biofortified corn flour and eggs retain vitamin A after cooking
November 17, 2017 - Integrated Care Winning the Day for Healthcare Companies
November 17, 2017 - CPAP may be superior to gastric banding for severe sleep apnea
November 17, 2017 - New pain relievers reduce opiate overdose risk
November 17, 2017 - Brain astrocytes could play key role in pathogenesis of Alzheimer’s disease
November 17, 2017 - Researchers test whether LVAD surgery could reverse frailty in older adults with heart failure
November 17, 2017 - ATS debuts new video to highlight dangers of flavored tobacco
November 17, 2017 - Medicaid expansion under ACA more likely to increase smoking cessation rates among low-income adults
November 17, 2017 - FDA Approves Mepsevii (vestronidase alfa) for Mucopolysaccharidosis Type VII
November 17, 2017 - 1 in 5 Americans Still Uses Tobacco, Gov’t. Reports: MedlinePlus Health News
November 17, 2017 - People with psychotic-like experiences spend less time in healthy brain states
November 17, 2017 - Hospital Readmission Reduction Program linked to increase in death rates, study finds
November 17, 2017 - Study finds rising rates of marijuana use in states where it is legal
November 17, 2017 - Scientists unveil pathology underlying optic nerve hypoplasia in children
November 17, 2017 - Novel device designed to treat diastolic heart failure found safe and effective
November 17, 2017 - Smoking parents may underestimate kid’s exposure to secondhand smoke
November 17, 2017 - FAIMS technology holds potential to be effective screening tool for pancreatic cancer
November 17, 2017 - Applying AFM to study the viscoelastic properties of cells
November 17, 2017 - FDA Alert: Nexterone (amiodarone HCl) 150 mg/100 mL Premixed Injection: Recall
November 17, 2017 - High cognitive ability not a safeguard from conspiracies, paranormal beliefs
Genetic checking out is helping set secure dose of not unusual blood thinner

Genetic checking out is helping set secure dose of not unusual blood thinner

image_pdfDownload PDFimage_print

Warfarin is a blood thinner this is recurrently prescribed to sufferers to stop life-threatening blood clots. In spite of its longtime use, warfarin stays tough to dose as a result of an individual’s genetic make-up influences how the drug is processed within the frame. An excessive amount of warfarin may cause inside bleeding; too little warfarin fails to stop blood clots.

Now, a brand new find out about led via Washington College Faculty of Medication in St. Louis presentations that dosing warfarin (Coumadin and others) is more secure—generating fewer opposed occasions equivalent to hemorrhage—when key components of a affected person’s genetic make-up are regarded as.

The analysis, printed Sept. 26 within the Magazine of the American Clinical Affiliation, experiences effects from the medical trial referred to as GIFT (Genetics Informatics Trial of Warfarin to Save you Deep Venous Thrombosis).

“Physicians were prescribing warfarin because the Eisenhower management,” mentioned first writer Brian F. Gage, MD, a professor of medication at Washington College Faculty of Medication in St. Louis. “It is a broadly used anticoagulant, however it reasons extra primary opposed occasions than another oral drug. 1000’s of sufferers finally end up within the emergency division or medical institution on account of warfarin-induced bleeding. However we proceed to prescribe it as a result of it’s extremely efficient, reversible and affordable. So our function is to make warfarin more secure. GIFT confirmed that precision-medicine according to medical elements and 3 genes improves the security of beginning warfarin treatment.”

Sufferers within the trial have been randomly assigned to one among two teams. One team won warfarin dosing according to same old elements equivalent to age, peak and weight; the second one team used to be dosed according to those medical elements plus genetic variants. Collaborating websites within the trial integrated Washington College Faculty of Medication, Clinic for Particular Surgical procedure in New York, Intermountain Healthcare, College of Utah, and Rush College Clinical Middle.

Of the 789 sufferers who have been dosed within the conventional approach, 116 skilled no less than one opposed tournament (14.7 p.c). Of the 808 sufferers whose warfarin dosing used to be guided via genetic checking out, 87 skilled an opposed tournament (10.eight p.c). In comparison with sufferers receiving conventional warfarin dosing, sufferers dosed with the genetic means had a 27 p.c relief in opposed occasions, which used to be statistically other. The opposed occasions have been bleeding, formation of blood clots within the veins and warfarin overdoses. No affected person died all through the trial.

Previous research having a look at whether or not genetic checking out may give a boost to warfarin dosing had produced conflicting effects. Alternatively, those research have been smaller and regarded as fewer genes than GIFT. GIFT enrolled 1,600 sufferers age 65 and older at top possibility of blood clots as a result of they underwent hip- or knee-replacement surgical procedures.

Not like prior research, GIFT took under consideration genetic variants in 3 genes for 11 days of warfarin treatment. Genetic variants have been assessed on a industrial platform known as GenMarkDx. Variants in a single gene have an effect on nutrition Ok recycling. Variants in any other gene have an effect on warfarin sensitivity. Variants within the 3rd gene modify warfarin metabolism within the liver and will purpose an overdose if the dose isn’t adjusted quickly sufficient.

“There are further genetic variants that can lend a hand to lead warfarin dosing, particularly amongst sufferers with African ancestry,” Gage mentioned. At some point, we are hoping to quantify how those variants have an effect on warfarin.”

Gage additionally famous how health-care prices relate to dosing warfarin in a genetically guided approach. “Even if genetic checking out is dearer than medical dosing, the price is falling,” he mentioned. “In our find out about, we estimated that genetic checking out prices not up to $200 in line with particular person, which is not up to one month of a more moderen anticoagulant.”


Discover additional:
Genetically guided warfarin dosing lowers possibility of a few opposed occasions

Additional info:
Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Li J, Rodriguez Jr. T, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, DeVore B, Porche-Sorbet R, Napoli L, Merritt Ok, Thompson AM, Hyun G, Anderson JL, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Davila-Roman V and Eby CS for the GIFT investigators. Impact of genotype-guided warfarin dosing on medical occasions and anticoagulation regulate amongst sufferers present process hip or knee arthroplasty: the GIFT randomized medical trial. Magazine of the American Clinical Affiliation. Sept. 26, 2017. DOI: 10.1001/jama.2017.11463

Magazine reference:
Magazine of the American Clinical Affiliation

Supplied via:
Washington College Faculty of Medication

Tagged with:

About author

Related Articles